The American Brachytherapy Society consensus statement for accelerated partial breast irradiation

Brachytherapy

Volumn 12, Issue 4, 2013, Pages 267-277

  Shah, Chirag ^a,b   Vicini, Frank ^c   Wazer, David E ^d,e   Arthur, Douglas ^f   Patel, Rakesh R ^g  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

^c 21ST CENTURY ONCOLOGY   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BROWN UNIVERSITY   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^g The Targeted Radiation Institute at VMOC   (United States)

Author keywords

Brachytherapy; Breast cancer; Breast conserving therapy; Guidelines; Partial breast irradiation

Indexed keywords

ESTROGEN RECEPTOR;

ACUTE TOXICITY; ARTICLE; BRACHYTHERAPY; BREAST CANCER; BREAST CARCINOMA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COMPUTER ASSISTED RADIOTHERAPY; CONSENSUS; DOSIMETRY; EARLY CANCER; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HEALTH CARE QUALITY; HISTOPATHOLOGY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LYMPH VESSEL METASTASIS; MASTECTOMY; MEDICAL SOCIETY; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AGE FACTORS; ANTINEOPLASTIC AGENTS, HORMONAL; BRACHYTHERAPY; BREAST NEOPLASMS; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; PATIENT SATISFACTION; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL; TAMOXIFEN;

EID: 84879460743     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2013.02.001     Document Type: Article

References (102)

1. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347:1233-1241.
2. Van Dongen J.A., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 2000, 92:1143-1150.
3. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002, 347:1227-1232.
4. Arndt V., Stegmaier C., Ziegler H., et al. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: A population-based study. J Cancer Res Clin Oncol 2008, 134:1311-1318.
5. Fisher B., Bryant J., Dignam J.J., et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2001, 20:4141-4149.
6. Fyles A.W., McCready D.R., Manchul L.A., et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 2004, 351:963-970.
7. Hughes K.S., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004, 351:971-977.
8. Veronesi U., Marubini E., Mariani L., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: Long-term results of a randomized trial. Ann Oncol 2001, 12:997-1003.
9. Darby S., McGale P., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: Meta-analysis of individual patient data on 10,801 women in 17 randomised trials. Lancet 2011, 378:1707-1716. Early Breast Cancer Trialists' Collaborative Group (EBCTG).
10. Hershman D.L., Buono D., McBride R.B., et al. Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. JNatl Cancer Inst 2008, 100:199-206.
11. Voti L., Richardson L.C., Reis I., et al. The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida. Breast Cancer Res Treat 2006, 95:89-95.
12. Husain Z.A., Mahmood U., Hanlon A., et al. Accelerated partial breast irradiation via brachytherapy: A patterns-of-care analysis with ASTRO consensus groupings. Brachytherapy 2011, 10:479-485.
13. American Brachytherapy Society: Breast Brachytherapy Task Group. Breast Brachytherapy. American Brachytherapy Society Web site. Available at: . Updated February 1, 2007. Accessed August 22,2012. http://www.americanbrachytherapy.org/guidelines/abs_breast_brachytherapy_taskgroup.pdf.
14. Smith B.D., Arthur D.W., Buchholz T.A., et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys 2009, 74:987-1001.
15. Polgar C., Van Limbergen E., Potter R., et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast conserving surgery: Recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol 2010, 94:264-273.
16. The American Society of Breast Surgeons. Consensus statement for accelerated partial breast irradiation. Am Soc Breast Surgeons Web site. Available at: . Updated August 15, 2012. Accessed August 22,2012. https://www.breastsurgeons.org/statements/PDF_Statements/APBI.pdf.
17. Ribeiro G.G., Magee B., Swindell R., et al. The Christie Hospital breast conservation trial: An update at 8 years from inception. Clin Oncol 1993, 5:278-283.
18. Dodwell D.J., Dyker K., Brown J., et al. A randomised study of whole-breast vs tumour-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol 2005, 17:618-622.
19. Polgar C., Fodor J., Major T., et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma-5-year results of a randomized trial. Int J Radiat Oncol Biol Phys 2007, 69:694-702.
20. Vaidya J.S., Joseph D.J., Tobias J.S., et al. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised non-inferiority phase 3 trial. Lancet 2010, 376:91-102.
21. Livi L., Buonamici F.B., Simontacchi G., et al. Accelerated partial breast irradiation with IMRT: New technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial. Int J Radiat Oncol Biol Phys 2010, 77:509-515.
22. Fentiman I.S., Poole C., Tong D., et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 1996, 32:608-611.
23. King T.A., Bolton J.S., Kuske R.R., et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000, 180:299-304.
24. Krishnan L., Jewell W.R., Tawfik O.W., et al. Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J 2001, 7:91-96.
25. Arthur D.W., Koo D., Zwicker R.D., et al. Partial breast brachytherapy after lumpectomy: Low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 2003, 56:681-689.
26. Perera F., Yu E., Engel J., et al. Patterns of breast recurrence in a pilot study of brachytherapy confined to the lumpectomy site for early breast cancer with six years' minimum follow-up. Int J Radiat Oncol Biol Phys 2003, 57:1239-1246.
27. Fentiman I.S., Deshmane V., Tong D., et al. Caesium(137) implant as sole radiation therapy for operable breast cancer: A phase II trial. Radiother Oncol 2004, 71:281-285.
28. Poti Z., Nemeskeri C., Fekeshazy A., et al. Partial breast irradiation with interstitial 60Co brachytherapy results in frequent grade 3 or 4 toxicity. Evidence based on a 12-year follow-up of 70 patients. Int J Radiat Oncol Biol Phys 2004, 58:1022-1033.
29. Slampa P., Soumarova R., Ruzickova J., et al. Pilot study of sole conformal perioperative interstitial brachyradiotherapy of early stage breast carcinoma using high-dose rate afterloading. Neoplasma 2005, 52:292-296.
30. Stevens M.J., Cooper S.G., Cross P., et al. Accelerated partial breast irradiation using interstitial high dose rate iridum brachytherapy: Early Australian experience and review of the literature. Australs Radiol 2006, 50:143-151.
31. Kaufman S.A., DiPetrillo T.A., Price L.L., et al. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/2 breast cancer. Brachytherapy 2007, 6:286-292.
32. Patel R.R., Christensen M.E., Hodge C.W., et al. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: Five-year results. Int J Radiat Oncol Biol Phys 2008, 70:970-973.
33. Gomez-Iturriaga A., Pina L., Cambeiro M., et al. Early breast cancer treated with conservative surgery, adjuvant chemotherapy, and delayed accelerated partial breast irradiation with high-dose-rate brachytherapy. Brachytherapy 2008, 7:310-315.
34. White J.R., Winter K.A., Kuske R.A., et al. Long-term outcome from RTOG 9517: A phase I/II study of accelerated partial breast irradiation (APBI) with multicatheter brachytherapy (MCT) following lumpectomy for early-stage breast cancer. J Clin Oncol 2012, 30:147.
35. Johansson B., Karlsson L., Liljegren G., et al. Pulsed dose rate brachytherapy as the sole adjuvant radiotherapy after breast-conserving surgery of T1-2 breast cancer: First long time results from a clinical study. Radiother Oncol 2009, 90:30-35.
36. Yoshida K., Nose T., Masuda N., et al. Preliminary result of accelerated partial breast irradiation after breast-conserving surgery. Breast Cancer 2009, 16:105-112.
37. Polgar C., Major T., Fodor J., et al. Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study. Radiother Oncol 2010, 94:274-279.
38. Hattangadi J.A., Powell S.N., Macdonald S.M., et al. Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial. Int J Radiat Oncol Biol Phys 2012, 83:791-800.
39. Strnad V., Hildebrandt G., Potter R., et al. Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery. Int J Radiat Oncol Biol Phys 2011, 80:17-24.
40. Shah C., Antonucci J.V., Wilkinson J.B., et al. Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: Results of a matched-pair analysis. Radiother Oncol 2011, 100:210-214.
41. Richards G.M., Berson A.M., Rescigno J., et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol 2004, 11:739-746.
42. Dowlatshahi K., Snider H.C., Gittleman M.A., et al. Early experience with balloon brachytherapy for breast cancer. Arch Surg 2004, 139:603-607.
43. Tsai P.I., Ryan M., Meek K., et al. Accelerated partial breast irradiation using the MammoSite device: Early technical experience and short-term clinical follow-up. Am Surg 2006, 72:929-934.
44. Niehoff P., Ballardini B., Polgar C., et al. Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer. Breast 2006, 15:319-325.
45. Niehoff P., Polgar C., Ostertag H., et al. Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: Results from an international phase II trial. Radiother Oncol 2006, 79:316-320.
46. Benitez P.R., Keisch M.E., Vicini F., et al. Five-year results: The initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer. Am J Surg 2007, 194:456-462.
47. Chao K.K., Vicini F.A., Wallace M., et al. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: The William Beaumont Hospital experience. Int J Radiat Oncol Biol Phys 2007, 69:32-40.
48. Cuttino L.W., Keisch M., Jenrette J.M., et al. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results. Int J Radiat Oncol Biol Phys 2008, 71:107-114.
49. Vicini F., Beitsch P., Quiet C., et al. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2011, 79:808-817.
50. Vicini F.A., Keisch M., Shah C., et al. Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy. Int J Radiat Oncol Biol Phys 2012, 83:512-518.
51. Leonard C., Carter D., Kercher J., et al. Prospective trial of accelerated partial breast intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2007, 67:1291-1298.
52. Hepel J.T., Tokita M., MacAusland S.G., et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2009, 75:1290-1296.
53. Jagsi R., Ben-David M.A., Moran J.M., et al. Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 2010, 76:71-78.
54. Vicini F., Winter K., Wong J., et al. Initial efficacy results of RTOG 0319: Three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/II breast carcinoma. Int J Radiat Oncol Biol Phys 2010, 77:1120-1127.
55. Chen P.Y., Wallace M., Mitchell C., et al. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2010, 76:991-997.
56. Hardee M.E., Raza S., Becker S.J., et al. Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: Comparable toxicity of IMRT versus 3D conformal technique. Int J Radiat Oncol Biol Phys 2012, 82:e415-e423.
57. Mussari S., Sabino Della Sala W., Busana L., et al. Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience. Strahlenther Onkol 2006, 182:589-595.
58. Beal K., McCormick B., Zelefsky M.J., et al. Single-fraction intraoperative radiotherapy for breast cancer: Early cosmetic results. Int J Radiat Oncol Biol Phys 2007, 69:19-24.
59. Sacchini V., Beal K., Goldberg J., et al. Study of quadrant high-dose intraoperative radiation therapy for early-stage breast cancer. Br J Surg 2008, 95:1105-1110.
60. Veronesi U., Orecchia R., Luini A., et al. Intraoperative radiotherapy during breast conserving surgery: A study on 1,822 cases treated with electrons. Breast Cancer Res Treat 2010, 124:141-151.
61. Kimple R.J., Klauber-DeMore N., Kuzmiak C.M., et al. Local control following single-dose intraoperative radiotherapy prior to surgical excision of early-stage breast cancer. Ann Surg Oncol 2011, 18:939-945.
62. Elliott R.L., DeLand M., Head J.F., Elliott M.C. Accelerated partial breast irradiation: Initial clinical experience with the Intrabeam System. Surg Oncol 2011, 20:73-79.
63. Kozak K.R., Smith B.L., Adams J., et al. Accelerated partial breast irradiation using proton beams: Initial clinical experience. Int J Radiat Oncol Biol Phys 2006, 66:691-698.
64. Bush D.A., Slater J.D., Garberoglio C., et al. Partial breast irradiation delivered with proton beam: Results of a Phase II trial. Clin Breast Cancer 2011, 11:241-245.
65. Shah C., Wilkinson J.B., Lyden M., et al. Comparison of survival and regional failure between accelerated partial breast irradiation and whole breast irradiation. Brachytherapy 2012, 11:311-315.
66. Julian T.B., Constantino J.P., Vicini F.A., et al. Early toxicity results with 3D conformal external beam (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial. J Clin Oncol 2011, 29(Suppl):S1011. [ASCO abstract 1011].
67. Whelan T.J., Olivotto I., Parpia S., et al. Interim toxicity results from RAPID: A randomized trial of accelerated partial breast irradiation (APBI) using 3D conformal external beam radiation therapy (3D CRT). Int J Radiat Oncol Biol Phys 2012, 84:S21.
68. Vaidya J.S. "Targeted intraoperative radiotherapy for early breast cancer: TARGIT-A trial-updated analysis of local recurrence and first analysis of survival". SABCS 2012, Abstract S4-S2.
69. Orecchia R. Eliot trials in Milan: Results. Radiother Oncol 2012, 103:S4.
70. National Comprehensive Cancer Network. Breast Cancer. NCCN Guidelines Web Site. Available at: . Updated July 11, 2012. Accessed August 22,2012. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site.
71. Shah C., Wilkinson J.B., Shaitelman S., et al. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma. Int J Radiat Oncol Biol Phys 2011, 81:e547-e551.
72. Jeruss J.S., Kuerer H.M., Beitsch P.D., et al. Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. Ann Surg Oncol 2011, 18:65-71.
73. Park S.S., Grills I.S., Chen P.Y., et al. Accelerated partial breast irradiation for pure ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 2011, 81:403-408.
74. Stull T.S., Goodwin M., Gracely E.J., et al. A single-institution review of accelerated partial breast irradiation in patients considered "cautionary" by the American Society for Radiation Oncology. Ann Surg Oncol 2012, 19:553-559.
75. Shah C., Vicini F., Wilkinson J.B., et al. Should ductal carcinoma in situ be removed from the ASTRO Consensus Panel Cautionary Group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI. Int J Radiat Oncol Biol Phys 2012, 84(Suppl):s3124. [ASTRO abstract 3124].
76. Vo T.N., Meric-Bernstam F., Yi M., et al. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg 2006, 192:552-555.
77. Moran M.S., Yang Q., Haffty B.G., et al. Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): Analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p.53 as a function of histology. Breast J 2009, 15:571-578.
78. Silverstein M.J., Lewinsky B.S., Waisman J.R., et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?. Cancer 1994, 73:1673-1677.
79. White J.R., Gustafson G.S., Wimbish K., et al. Conservative surgery and radiation therapy for infiltrating lobular carcinoma of the breast. The role of preoperative mammograms in guiding treatment. Cancer 1994, 74:640-647.
80. Shah C., Wilkinson J.B., Shaitelman S., et al. Impact of lymph node status on clinical outcomes after accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2012, 82:e409-e414.
81. Whelan T.J., Olivotto I., Ackerman I., et al. NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer. J Clin Oncol 2011, 29(Suppl):S1003. [ASCO abstract LBA1003].
82. Kunkler I.H., Kerr G.R., Thomas J.S., et al. Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: Results from a large series with long-term follow-up. Int J Radiat Oncol Biol Phys 2012, 83:829-838.
83. Shah C., Wilkinson J.B., Lyden M., et al. Predictors of local recurrence following accelerated partial breast irradiation: A pooled analysis. Int J Radiat Oncol Biol Phys 2012, 82:e825-e830.
84. Magee B., Swindell R., Harris M., et al. Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: Results from a randomised trial. Radiother Oncol 1996, 39:223-227.
85. Wilder R.B., Curcio L.D., Khanijou R.K., et al. Preliminary results with accelerated partial breast irradiation in high-risk breast cancer patients. Brachytherapy 2010, 9:171-177.
86. Khan A.J., Vicini F.A., Beitsch P., et al. Local control, toxicity, and cosmesis in women >70 years enrolled in the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial. Int J Radiat Oncol Biol Phys 2012, 84:323-330.
87. Hunt K.K., Ballman K.V., McCall L.M., et al. Factors associated with local-regional recurrence after negative sentinel node dissection: Results of the ACOSOG Z0010 trial. Ann Surg 2012, 256:428-436.
88. Tendulkar R.D., Rehman S., Shukla M.E., et al. Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy. Int J Radiat Oncol Biol Phys 2012, 83:e577-e581.
89. Lowery A.J., Kell M.R., Glynn R.W., et al. Locoregional recurrence after breast cancer surgery: A systematic review by receptor phenotype. Breast Cancer Res Treat 2012, 133:831-841.
90. Park C.C., Mitsumori M., Nixon A., et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 2000, 18:1668-1675.
91. Yeo S.G., Kim J., Kwak G.H., et al. Accelerated partial breast irradiation using multicatheter brachytherapy for select early-stage breast cancer: Local control and toxicity. Radiat Oncol 2010, 5:56.
92. Jawad M.S., Wilkinson J.B., Shah C., et al. Impact of lymphovascular space invasion, extensive intraductal component, and multi-focality following accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2012, 84(Suppl):s1049. [ASTRO Abstract 1049].
93. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007, 25:3259-3265.
94. Aburabia M., Roses R.E., Kuerer H.M., et al. Axillary failure in patients treated with MammoSite accelerated partial breast irradiation. Ann Surg Oncol 2011, 18:3415-3421.
95. Leong C., Boyages J., Jayasinghe U.W., et al. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. Cancer 2004, 100:1823-1832.
96. Wazer D.E., Hepel J.T. A comparison of brachytherapy techniques for partial breast irradiation. Brachytherapy 2012, 11:163-175.
97. Guinot J.L., Tortajada M.I., Carrascosa M., et al. Ten-year results of a phase II study with single fraction of high-dose-rate brachytherapy (FAST-boost) after whole breast irradiation in invasive breast carcinoma. Clin Transl Oncol 2012, 14:109-115.
98. Schroeder T.M., Liem B., Sampath S., et al. Early breast cancer with positive margins: Excellent local control with an upfront brachytherapy boost. Breast Cancer Res Treat 2012, 134:719-725.
99. Pan Q., Calitschi E., Otmezguine Y., et al. Long term results of exclusive radiotherapy and brachytherapy of breast cancer. Cancer Radiother 2012, 16:674-680.
100. Sioshansi S., Rivard M.J., Hiatt J.R., et al. Dose modeling of noninvasive image-guided breast brachytherapy in comparison to electron beam boost and three-dimensional conformal accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 2011, 80:410-416.
101. Hamid S., Rocchio K., Arthur D., et al. A multi-institutional study of feasibility, implementation, and early clinical results with noninvasive breast brachytherapy for tumor bed boost. Int J Radiat Oncol Biol Phys 2012, 83:1374-1380.
102. National Institutes of Health. Partial breast irradiation using non-invasive machine for early stage breast cancer. Clinical Trials.gov. Available at: . Updated July 5, 2012. Accessed August 22,2012. http://www.clinicaltrials.gov/ct2/show/NCT01463007?term=APBI+breast&rank=12.